Esperion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.About ESPR
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
CEOSheldon L. Koenig
CEOSheldon L. Koenig
Employees240
Employees240
HeadquartersAnn Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded1998
Founded1998
Employees240
Employees240
ESPR Key Statistics
Market cap401.33M
Market cap401.33M
Price-Earnings ratio-2.35
Price-Earnings ratio-2.35
Dividend yield—
Dividend yield—
Average volume11.85M
Average volume11.85M
High today$2.61
High today$2.61
Low today$2.33
Low today$2.33
Open price$2.60
Open price$2.60
Volume8.20M
Volume8.20M
52 Week high$3.40
52 Week high$3.40
52 Week low$0.70
52 Week low$0.70
ESPR News
TipRanks 4d
Esperion receives five year patent extension for bempedoic acidEsperion announced today that the U.S. Patent and Trademark Office, USPTO, issued a U.S. Patent Term Extension, PTE, certificate for bempedoic acid, which is co...
Analyst ratings
63%
of 8 ratingsBuy
62.5%
Hold
37.5%
Sell
0%